Submitted:
06 January 2024
Posted:
08 January 2024
You are already at the latest version
Abstract
Keywords:
1. Introduction
- Duodenal motility
2. Analysis of the Vascular Hypothesis of the Pathogenesis of Smas
- 1.
- Analysis of radiological studies in the so-called SMAS
- 2.
- On the pathogenesis of the so-called SMAS
- 3
- What does the AMA value indicate?
3. Clinical Analysis of 227 Cases of Smas
4. What does the AMA angle depend on?
5. Etiology, pathogenesis, diagnosis, and treatment of Ochsner`s sphincter dyskinesia.
- Etiology
- 2.
- Pathogenesis
- 3.
- Diagnosis
- 4.
- Treatment
6. Discussion

7. Conclusions
References
- van Beek, A.P.; Emous, M.; Laville, M.; JTack, J. Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management. Obes Rev. 2017, 18, 68–85. [Google Scholar] [CrossRef]
- Ochsner, A.J., VIII. Construction of the Duodenum Below the Entrance of the Common Duct and Its Relation to Disease. Ann Surg. 1906, 43, 80–87. [Google Scholar] [CrossRef]
- Aldot, G.; Kapandji, M.; Ringendach, J. Physiology of timed duodenal intubation. II. Role of Ochsner's sphincter in the mechanism of normal duodenal intubation and in that of certain prolongations of so-called 13 Oddi's closed time. Arch Mal Appar Dig Mal Nutr. 1956, 45, 449–457. [Google Scholar]
- Levin, M.D.; Korshun, Z.; Mendelson, G. [Duodenal motility in norm and in some diseases. Hypothesis]. Ter Arkh. 2016, 88, 68–74. [Google Scholar] [CrossRef]
- Levin, M.D. Ochsner's Sphincter Dyskinesia Is the Cause of Superior Mesenteric Artery Syndrome. J Gastrointest Surg. 2019, 23, 1714–1716. [Google Scholar] [CrossRef]
- Levin, M.D. Sphincter Ochsner dyskinesia as a cause of superior mesenteric artery syndrome. Review. Vestn Rentgenol Radiol. 2016, 97, 110–117. [Google Scholar] [CrossRef]
- Levin, M.D. PATHOGENETIC SIGNIFICANCE OF DYSKINESIA OF THE SPHINCTER OF OKSNER IN THE DEVELOPMENT OF THE SYNDROME OF THE SUPERIOR MESENTERIC ARTERY. Review. Eksp Klin Gastroenterol. 2016, 12, 67–72. [Google Scholar]
- Biank, V.; Werlin, S. Superior mesenteric artery syndrome in children: a 20- year experience. J Pediatr Gastroenterol Nutr. 2006, 42, 522–525. [Google Scholar] [CrossRef]
- Santer, R.; CYoung, C.; Rossi, T.; Riddlesberger, M.M. Computed tomography in superior mesenteric artery syndrome. Pediatr Radiol. 1991, 21, 154–155. [Google Scholar] [CrossRef] [PubMed]
- Neri, S.; Signorelli, S.S.; Mondati, E.; et al. Ultrasound imaging in diagnosis of superior mesenteric artery syndrome. J Intern Med. 2005, 257, 346–351. [Google Scholar] [CrossRef] [PubMed]
- Diagnostic imaging in internal medicine. By R.L. Eisenberg. Copyright © 1985 by McGraw-Hill, Inc. p.694.
- Bhagirath Desai, A.; Sandeep Shah, D.; Jagat Bhatt, C.; et al. Measurement of the Distance and Angle Between the Aorta and Superior Mesenteric Artery on CTScan: Values in Indian Population in Different B MI Categories. Indian J Surg. 2015, 77 (Suppl 2), 614–617. [Google Scholar] [CrossRef] [PubMed]
- Alzerwi, N.A.N. Predictors of Superior Mesenteric Artery Syndrome: Evidence from a Case-Control Study. Cureus. 2020, 12, e9715. [Google Scholar] [CrossRef] [PubMed]
- Lenz, K.1.; Buder, R.; Firlinger, F.; Lohr, G.; Voglmayr, M. Effect of proton pump inhibitors on gastric pH in patients exposed to severe stress. Wien Klin Wochenschr. 2014, 127, 51–56. [Google Scholar] [CrossRef]
- Cuomo, R.; Andreozzi, P.; Zito, F.P.; et al. Irritable bowel syndrome and food interaction. World J Gastroenterol. 2014, 20, 8837–8845. [Google Scholar] [CrossRef] [PubMed]
- Konturek, P.C.; Brzozowski, T.; Konturek, S.J. Stress and the gut: pathophysiology, clinical consequences, diagnostic approach and treatment options. J Physiol Pharmacol. 2011, 62, 591–599. [Google Scholar]
- Minenna, M.F.; Palieri, A.; Panella, C.; Ierardi, E. Gastro-oesophageal reflux disease and lactose malabsorption: Casual comorbidity or neglected association? Dig Liver Dis. 2006, 38, 437–438. [Google Scholar] [CrossRef]
- Comas-Basté, O.; Sánchez-Pérez, S.; Veciana-Nogués, M.T.; et al. Histamine Intolerance: The Current State of the Art. Biomolecules. 2020, 10, 1181. [Google Scholar] [CrossRef] [PubMed]
- Barkun, A.N.; Almadi, M.; Kuipers, E.J.; et al. Management of Nonvariceal Upper Gastrointestinal Bleeding: Guideline Recommendations From the International Consensus Group. Ann Intern Med. 2019, 171, 805–822. [Google Scholar] [CrossRef] [PubMed]
- Pang, S.H.; Graham, D.Y. A clinical guide to using intravenous proton-pump inhibitors in reflux and peptic ulcers. Therap Adv Gastroenterol. 2010, 3, 11–22. [Google Scholar] [CrossRef]
- Kim, J.Y.; Shin, M.S.; Lee, S. Endoscopic features for early decision to evaluate superior mesenteric artery syndrome in children. BMC Pediatr. 2021, 21, 392. [Google Scholar] [CrossRef]
- Livzan, M.A.; Mozgovoi, S.I.; Gaus, O.V.; Bordin, D.S.; Kononov, A.V. Diagnostic Principles for Chronic Gastritis Associated with Duodenogastric Reflux. Diagnostics (Basel). 2023, 13, 186. [Google Scholar] [CrossRef] [PubMed]
- Caterine, S.; Patil, N.S.; Takrouri, H.; Issenman, R.M.; Stein, N.R.; Donnellan, J.; Yikilmaz, A. Understanding the diagnosis of superior mesenteric artery syndrome: analysis of the location of duodenal impression on upper gastrointestinal studies. Pediatr Radiol. 2023, 53, 2633–2641. [Google Scholar] [CrossRef] [PubMed]
- Dross, P.E.; Shawdon Molavi, S.; Alex Chan, A.; Latshaw, R.; Chhabra, P. Unusual Etiologies for Vascular Duodenal Compression Mimicking the Superior Mesenteric Artery (SMA) Syndrome: The SMA-Like Syndrome. J Gastrointestinal Abdominal Radiol ISGAR 2019, 2, 140–146. [Google Scholar] [CrossRef]
- Oka, A.; Awoniyi, M.; Hasegawa, N.; Yoshida, Y.; Tobita, H.; Ishimura, N.; Ishihara, S. Superior mesenteric artery syndrome: Diagnosis and management. World J Clin Cases. 2023, 11, 3369–3384. [Google Scholar] [CrossRef] [PubMed]





| Groups | Number of patients | Age (years) |
M/W | Duration of The disease |
Weight loss (kg) | BMI | Conservative treatment |
Treatment time (days) | Surgery without Conservative treatment |
|---|---|---|---|---|---|---|---|---|---|
| 1st group | 101 | 3-81 25.8±3.4 |
44/56 | 1-53 days 8,2±1.9 |
3-17 13.6±3.6 |
14-21 18.9±0.9 |
88.9% | 2-59 13.4±2.9 |
4% |
| 2nd group | 110 | 17-86 36.7±2.2 |
52/58 | 3-72 months 17.2±3.2 |
3-29 18.0±4.3 |
15 – 28 16.0±3.6 |
39% | ? | 47% |
| 211 | p<0.001 | p<0.001 | p>0.2 | p>0.2 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).